Rivastigmine 15 (Apo)
What it is used for
APO-RIVASTIGMINE PATCH is indicated for the treatment of patients with mild, moderate and severe dementia of the Alzheimers type.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient rivastigmine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Visual appearance
Circular 15cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with “Rivastigmine 13.3 mg/24 h”